Handelsbanken Fonder’s Immunovant IMVT Stock Holding History

Handelsbanken Fonder’s Portfolio IMVT Stock Details IMVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.33M	Buy	34,500 +2,200	+7%	+$67K	﹤0.01%	1004
2026 Q1	$802K	Hold	32,300	–	–	﹤0.01%	1135
2025 Q4	$821K	Buy	32,300 +8,500	+36%	+$190K	﹤0.01%	1126
2025 Q3	$384K	Hold	23,800	–	–	﹤0.01%	1366
2025 Q2	$381K	Buy	23,800 +2,900	+14%	+$43.9K	﹤0.01%	1355
2025 Q1	$357K	Hold	20,900	–	–	﹤0.01%	1352
2024 Q4	$518K	Hold	20,900	–	–	﹤0.01%	1270
2024 Q3	$596K	Buy	20,900 +4,700	+29%	+$139K	﹤0.01%	1174
2024 Q2	$428K	Buy	16,200 +4,400	+37%	+$125K	﹤0.01%	1219
2024 Q1	$381K	Hold	11,800	–	–	﹤0.01%	1287
2023 Q4	$497K	Buy	11,800 +2,900	+33%	+$107K	﹤0.01%	1153
2023 Q3	$342K	Buy	+8,900	New	+$201K	﹤0.01%	1253
2021 Q1	–	Sell	-7,100	Closed	-$328K	–	1572
2020 Q4	$328K	Buy	+7,100	New	+$328K	﹤0.01%	1363

Other funds holding IMVT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Handelsbanken Fonder's IMVT Position: Q2 2026 in Review

Handelsbanken Fonder increased its Immunovant (IMVT) stake by 6.8% in Q2 2026, buying an estimated $67K and bringing the position to 34,500 shares worth $1.33M. The position accounts for ﹤0.01% of the portfolio, ranked #1004.

Handelsbanken Fonder first reported a position in IMVT in Q4 2020 and has held it in 13 quarters since. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

Handelsbanken Fonder held 34,500 shares of Immunovant worth $1.33M as of Q2 2026.
Handelsbanken Fonder bought 2,200 Immunovant shares in Q2 2026, an estimated $67K.
Immunovant made up ﹤0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #1004 holding.
Handelsbanken Fonder first reported a position in Immunovant in Q4 2020 and has held it in 13 quarters since.
226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.